Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-04-11

AUTHORS

Jing Fang, Wenge Li, Min Tan, Wen Chen, Cong Zhang, Wenbo Wang, Qianqian Xu, Xinzhen Guo

ABSTRACT

PurposeAntiviral prophylaxis is proved to be effective in reducing the risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)-positive patients under immunotherapy. But outcomes referring to discontinuation of antiviral prophylaxis in these patients are lacking.MethodsWe performed a retrospective study of 105 HBsAg-positive patients under immunotherapy for glomerulonephritis and evaluated the incidence and risk factors for HBV reactivation.ResultsAmong 105 patients, 55.24% completed antiviral prophylaxis, while 20.00% discontinued and 24.76% rejected antiviral prophylaxis. HBV reactivation was significantly different among completion, discontinuation, and rejection of antiviral prophylaxis: 5.17% versus 38.10% versus 15.38% in the incidence of HBV reactivation (P = 0.001), 3.45% versus 23.81% versus 11.54% in HBV DNA ≥ 5 Log copies/ml (P = 0.023), and 0 versus 14.29% versus 3.85% in hepatitis B e antigen seroconversion from negative to positive (P = 0.014). Survival curve showed the median occurrence time of HBV reactivation in discontinuation group was 32 months (95% CI 24–39 months), earlier than 69 months (95% CI 65–72 months) of completion group and 43 months (95% CI 37–49 months) of rejection group (χ2 = 13.780, P = 0.001). Univariate and multivariate analysis identified two independent risk factors for HBV reactivation: baseline HBV DNA detectable (OR 5.009, 95% CI 1.717–16.335, P = 0.012) and discontinuation of antiviral prophylaxis (OR 5.213, 95% CI 1.688–18.105, P = 0.011).ConclusionsDiscontinuation of antiviral prophylaxis increased the risk of HBV reactivation in HBsAg-positive patients under immunotherapy for glomerulonephritis. More... »

PAGES

1653-1660

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11255-018-1867-0

DOI

http://dx.doi.org/10.1007/s11255-018-1867-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103220807

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29644524


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerulonephritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B Surface Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B e Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Virus Activation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fang", 
        "givenName": "Jing", 
        "id": "sg:person.0750716622.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750716622.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Wenge", 
        "id": "sg:person.0657737640.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657737640.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Min", 
        "id": "sg:person.01021453055.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021453055.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Wen", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Cong", 
        "id": "sg:person.01204014655.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204014655.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Wenbo", 
        "id": "sg:person.014261320265.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014261320265.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Qianqian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatology, China-Japan Friendship Hospital, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.415954.8", 
          "name": [
            "Department of Hepatology, China-Japan Friendship Hospital, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Xinzhen", 
        "id": "sg:person.014535743471.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014535743471.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2334-13-394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007529388", 
          "https://doi.org/10.1186/1471-2334-13-394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-011-0464-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022893945", 
          "https://doi.org/10.1007/s10157-011-0464-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11255-016-1487-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009194155", 
          "https://doi.org/10.1007/s11255-016-1487-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-010-0331-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008978752", 
          "https://doi.org/10.1007/s00535-010-0331-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601699", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051534210", 
          "https://doi.org/10.1038/sj.bjc.6601699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2010.70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007689036", 
          "https://doi.org/10.1038/bmt.2010.70"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11255-013-0480-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048726153", 
          "https://doi.org/10.1007/s11255-013-0480-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12882-017-0788-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099737802", 
          "https://doi.org/10.1186/s12882-017-0788-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-04-11", 
    "datePublishedReg": "2018-04-11", 
    "description": "PurposeAntiviral prophylaxis is proved to be effective in reducing the risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)-positive patients under immunotherapy. But outcomes referring to discontinuation of antiviral prophylaxis in these patients are lacking.MethodsWe performed a retrospective study of 105 HBsAg-positive patients under immunotherapy for glomerulonephritis and evaluated the incidence and risk factors for HBV reactivation.ResultsAmong 105 patients, 55.24% completed antiviral prophylaxis, while 20.00% discontinued and 24.76% rejected antiviral prophylaxis. HBV reactivation was significantly different among completion, discontinuation, and rejection of antiviral prophylaxis: 5.17% versus 38.10% versus 15.38% in the incidence of HBV reactivation (P\u2009=\u20090.001), 3.45% versus 23.81% versus 11.54% in HBV DNA\u2009\u2265\u20095 Log copies/ml (P\u2009=\u20090.023), and 0 versus 14.29% versus 3.85% in hepatitis B e antigen seroconversion from negative to positive (P\u2009=\u20090.014). Survival curve showed the median occurrence time of HBV reactivation in discontinuation group was 32\u00a0months (95% CI 24\u201339\u00a0months), earlier than 69\u00a0months (95% CI 65\u201372\u00a0months) of completion group and 43\u00a0months (95% CI 37\u201349\u00a0months) of rejection group (\u03c72\u2009=\u200913.780, P\u2009=\u20090.001). Univariate and multivariate analysis identified two independent risk factors for HBV reactivation: baseline HBV DNA detectable (OR 5.009, 95% CI 1.717\u201316.335, P\u2009=\u20090.012) and discontinuation of antiviral prophylaxis (OR 5.213, 95% CI 1.688\u201318.105, P\u2009=\u20090.011).ConclusionsDiscontinuation of antiviral prophylaxis increased the risk of HBV reactivation in HBsAg-positive patients under immunotherapy for glomerulonephritis.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11255-018-1867-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1014320", 
        "issn": [
          "0924-8455", 
          "1573-7306"
        ], 
        "name": "International Urology and Nephrology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "50"
      }
    ], 
    "keywords": [
      "hepatitis B virus reactivation", 
      "HBsAg-positive patients", 
      "antiviral prophylaxis", 
      "HBV reactivation", 
      "virus reactivation", 
      "HBV DNA", 
      "risk factors", 
      "hepatitis B e antigen (HBeAg) seroconversion", 
      "hepatitis B surface antigen", 
      "baseline HBV DNA", 
      "independent risk factor", 
      "log copies/", 
      "median occurrence time", 
      "antigen (HBeAg) seroconversion", 
      "discontinuation group", 
      "rejection group", 
      "glomerulonephritis patients", 
      "retrospective study", 
      "copies/", 
      "prophylaxis", 
      "discontinuation", 
      "patients", 
      "immunotherapy", 
      "surface antigen", 
      "survival curves", 
      "completion group", 
      "months", 
      "glomerulonephritis", 
      "risk", 
      "incidence", 
      "reactivation", 
      "group", 
      "seroconversion", 
      "real-life observations", 
      "MethodsWe", 
      "antigen", 
      "outcomes", 
      "factors", 
      "rejection", 
      "completion", 
      "DNA", 
      "study", 
      "time", 
      "curves", 
      "analysis", 
      "observations", 
      "occurrence time", 
      "PurposeAntiviral prophylaxis", 
      "B virus (HBV) reactivation", 
      "B surface antigen", 
      "ResultsAmong 105 patients", 
      "B e antigen seroconversion", 
      "e antigen seroconversion", 
      "ConclusionsDiscontinuation"
    ], 
    "name": "Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation", 
    "pagination": "1653-1660", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103220807"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11255-018-1867-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29644524"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11255-018-1867-0", 
      "https://app.dimensions.ai/details/publication/pub.1103220807"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_785.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11255-018-1867-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11255-018-1867-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11255-018-1867-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11255-018-1867-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11255-018-1867-0'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      22 PREDICATES      106 URIs      90 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11255-018-1867-0 schema:about N0215075dbb0045169b0c7f819c333743
2 N364ecfd109d54e289ad2072480ab7c1f
3 N3ecee312302c4d42a99c1352b78b86fe
4 N4ef280893d024b9b9eeecb3d247b6687
5 N56fbe54869ed464b97f9cccb3727c11f
6 N5fdef3b0306b4a398f2915c876fe5be3
7 N690deda51dd54f53a81cd6f52bddab85
8 N6c393dcc839f493a9f30d6334e63ed2c
9 N6d51159281f64a0ba452c32b0d280be3
10 N7d8ecd67e8434979bb6645be72d39ef9
11 N8ec3431b9ea840508dc03935a483fe24
12 N910c2312fbb94ccca2d4a7d78432273f
13 N92f8f89fe9c94b5da6d3cb6e4c90d839
14 N9756df45a97e4cb092d7cfdd305acd97
15 Nbfacc8d939dd4a11a0adde58ce922edc
16 Nca411463a1e34243ab1696b09e1f9883
17 Ne499007e3b5643d9bd3693f668c9cd2f
18 Nef04f091344d47b1b026d22cb1615ff8
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Ne89f2851640f4f49b637e4ebcc3df2db
22 schema:citation sg:pub.10.1007/s00535-010-0331-4
23 sg:pub.10.1007/s10157-011-0464-7
24 sg:pub.10.1007/s11255-013-0480-5
25 sg:pub.10.1007/s11255-016-1487-5
26 sg:pub.10.1038/bmt.2010.70
27 sg:pub.10.1038/sj.bjc.6601699
28 sg:pub.10.1186/1471-2334-13-394
29 sg:pub.10.1186/s12882-017-0788-y
30 schema:datePublished 2018-04-11
31 schema:datePublishedReg 2018-04-11
32 schema:description PurposeAntiviral prophylaxis is proved to be effective in reducing the risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)-positive patients under immunotherapy. But outcomes referring to discontinuation of antiviral prophylaxis in these patients are lacking.MethodsWe performed a retrospective study of 105 HBsAg-positive patients under immunotherapy for glomerulonephritis and evaluated the incidence and risk factors for HBV reactivation.ResultsAmong 105 patients, 55.24% completed antiviral prophylaxis, while 20.00% discontinued and 24.76% rejected antiviral prophylaxis. HBV reactivation was significantly different among completion, discontinuation, and rejection of antiviral prophylaxis: 5.17% versus 38.10% versus 15.38% in the incidence of HBV reactivation (P = 0.001), 3.45% versus 23.81% versus 11.54% in HBV DNA ≥ 5 Log copies/ml (P = 0.023), and 0 versus 14.29% versus 3.85% in hepatitis B e antigen seroconversion from negative to positive (P = 0.014). Survival curve showed the median occurrence time of HBV reactivation in discontinuation group was 32 months (95% CI 24–39 months), earlier than 69 months (95% CI 65–72 months) of completion group and 43 months (95% CI 37–49 months) of rejection group (χ2 = 13.780, P = 0.001). Univariate and multivariate analysis identified two independent risk factors for HBV reactivation: baseline HBV DNA detectable (OR 5.009, 95% CI 1.717–16.335, P = 0.012) and discontinuation of antiviral prophylaxis (OR 5.213, 95% CI 1.688–18.105, P = 0.011).ConclusionsDiscontinuation of antiviral prophylaxis increased the risk of HBV reactivation in HBsAg-positive patients under immunotherapy for glomerulonephritis.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N43e02e4e10d243658c131e528c533b1d
37 Nf7a16a69ada04515a9574bda5952fcbe
38 sg:journal.1014320
39 schema:keywords B e antigen seroconversion
40 B surface antigen
41 B virus (HBV) reactivation
42 ConclusionsDiscontinuation
43 DNA
44 HBV DNA
45 HBV reactivation
46 HBsAg-positive patients
47 MethodsWe
48 PurposeAntiviral prophylaxis
49 ResultsAmong 105 patients
50 analysis
51 antigen
52 antigen (HBeAg) seroconversion
53 antiviral prophylaxis
54 baseline HBV DNA
55 completion
56 completion group
57 copies/
58 curves
59 discontinuation
60 discontinuation group
61 e antigen seroconversion
62 factors
63 glomerulonephritis
64 glomerulonephritis patients
65 group
66 hepatitis B e antigen (HBeAg) seroconversion
67 hepatitis B surface antigen
68 hepatitis B virus reactivation
69 immunotherapy
70 incidence
71 independent risk factor
72 log copies/
73 median occurrence time
74 months
75 observations
76 occurrence time
77 outcomes
78 patients
79 prophylaxis
80 reactivation
81 real-life observations
82 rejection
83 rejection group
84 retrospective study
85 risk
86 risk factors
87 seroconversion
88 study
89 surface antigen
90 survival curves
91 time
92 virus reactivation
93 schema:name Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation
94 schema:pagination 1653-1660
95 schema:productId N679a259010e046b69b0f018d6c3f205a
96 N6d9b2c61d36c4c789b6eac663252a793
97 Ne3c48bfc7e054a16bfc7d183c0700fcc
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103220807
99 https://doi.org/10.1007/s11255-018-1867-0
100 schema:sdDatePublished 2021-12-01T19:42
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N41462b18281b40379da8cbfc3e6a165f
103 schema:url https://doi.org/10.1007/s11255-018-1867-0
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N0215075dbb0045169b0c7f819c333743 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Male
109 rdf:type schema:DefinedTerm
110 N305f988a65434943b842805f12468b35 schema:affiliation grid-institutes:grid.415954.8
111 schema:familyName Xu
112 schema:givenName Qianqian
113 rdf:type schema:Person
114 N364ecfd109d54e289ad2072480ab7c1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adult
116 rdf:type schema:DefinedTerm
117 N3975287d5da340d39af3ee45be5e585c schema:affiliation grid-institutes:grid.415954.8
118 schema:familyName Chen
119 schema:givenName Wen
120 rdf:type schema:Person
121 N3ecee312302c4d42a99c1352b78b86fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Risk Factors
123 rdf:type schema:DefinedTerm
124 N41462b18281b40379da8cbfc3e6a165f schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N43e02e4e10d243658c131e528c533b1d schema:volumeNumber 50
127 rdf:type schema:PublicationVolume
128 N4e2e08b14e574c478190bc14d66e2e98 rdf:first sg:person.01204014655.07
129 rdf:rest N88b6b1424bfb41ed9514b2fa6444b640
130 N4ef280893d024b9b9eeecb3d247b6687 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Middle Aged
132 rdf:type schema:DefinedTerm
133 N56fbe54869ed464b97f9cccb3727c11f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Retrospective Studies
135 rdf:type schema:DefinedTerm
136 N5fdef3b0306b4a398f2915c876fe5be3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Immunosuppressive Agents
138 rdf:type schema:DefinedTerm
139 N679a259010e046b69b0f018d6c3f205a schema:name dimensions_id
140 schema:value pub.1103220807
141 rdf:type schema:PropertyValue
142 N690deda51dd54f53a81cd6f52bddab85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Glomerulonephritis
144 rdf:type schema:DefinedTerm
145 N6c393dcc839f493a9f30d6334e63ed2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Hepatitis B
147 rdf:type schema:DefinedTerm
148 N6d51159281f64a0ba452c32b0d280be3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Female
150 rdf:type schema:DefinedTerm
151 N6d9b2c61d36c4c789b6eac663252a793 schema:name pubmed_id
152 schema:value 29644524
153 rdf:type schema:PropertyValue
154 N7d8ecd67e8434979bb6645be72d39ef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Antibodies, Viral
156 rdf:type schema:DefinedTerm
157 N88b6b1424bfb41ed9514b2fa6444b640 rdf:first sg:person.014261320265.66
158 rdf:rest Neb60d68ce21c4100b7e2239460bb2c23
159 N8ec3431b9ea840508dc03935a483fe24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 N910c2312fbb94ccca2d4a7d78432273f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name DNA, Viral
164 rdf:type schema:DefinedTerm
165 N92f8f89fe9c94b5da6d3cb6e4c90d839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Recurrence
167 rdf:type schema:DefinedTerm
168 N9756df45a97e4cb092d7cfdd305acd97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Hepatitis B Surface Antigens
170 rdf:type schema:DefinedTerm
171 Na3f7ddf1f264492bb7cad35f170946c4 rdf:first sg:person.014535743471.81
172 rdf:rest rdf:nil
173 Na6d89c5fcb1c4fc8a87587b8d044002c rdf:first sg:person.01021453055.14
174 rdf:rest Nd040de3f52544317bf6f30228fe1f5bc
175 Nbfacc8d939dd4a11a0adde58ce922edc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Hepatitis B virus
177 rdf:type schema:DefinedTerm
178 Nca411463a1e34243ab1696b09e1f9883 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Hepatitis B e Antigens
180 rdf:type schema:DefinedTerm
181 Nd040de3f52544317bf6f30228fe1f5bc rdf:first N3975287d5da340d39af3ee45be5e585c
182 rdf:rest N4e2e08b14e574c478190bc14d66e2e98
183 Ne3c48bfc7e054a16bfc7d183c0700fcc schema:name doi
184 schema:value 10.1007/s11255-018-1867-0
185 rdf:type schema:PropertyValue
186 Ne499007e3b5643d9bd3693f668c9cd2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Virus Activation
188 rdf:type schema:DefinedTerm
189 Ne89f2851640f4f49b637e4ebcc3df2db rdf:first sg:person.0750716622.35
190 rdf:rest Nef8af157776a4b778c8cc813aa124c54
191 Neb60d68ce21c4100b7e2239460bb2c23 rdf:first N305f988a65434943b842805f12468b35
192 rdf:rest Na3f7ddf1f264492bb7cad35f170946c4
193 Nef04f091344d47b1b026d22cb1615ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Antiviral Agents
195 rdf:type schema:DefinedTerm
196 Nef8af157776a4b778c8cc813aa124c54 rdf:first sg:person.0657737640.89
197 rdf:rest Na6d89c5fcb1c4fc8a87587b8d044002c
198 Nf7a16a69ada04515a9574bda5952fcbe schema:issueNumber 9
199 rdf:type schema:PublicationIssue
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
204 schema:name Clinical Sciences
205 rdf:type schema:DefinedTerm
206 sg:journal.1014320 schema:issn 0924-8455
207 1573-7306
208 schema:name International Urology and Nephrology
209 schema:publisher Springer Nature
210 rdf:type schema:Periodical
211 sg:person.01021453055.14 schema:affiliation grid-institutes:grid.415954.8
212 schema:familyName Tan
213 schema:givenName Min
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021453055.14
215 rdf:type schema:Person
216 sg:person.01204014655.07 schema:affiliation grid-institutes:grid.415954.8
217 schema:familyName Zhang
218 schema:givenName Cong
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204014655.07
220 rdf:type schema:Person
221 sg:person.014261320265.66 schema:affiliation grid-institutes:grid.415954.8
222 schema:familyName Wang
223 schema:givenName Wenbo
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014261320265.66
225 rdf:type schema:Person
226 sg:person.014535743471.81 schema:affiliation grid-institutes:grid.415954.8
227 schema:familyName Guo
228 schema:givenName Xinzhen
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014535743471.81
230 rdf:type schema:Person
231 sg:person.0657737640.89 schema:affiliation grid-institutes:grid.415954.8
232 schema:familyName Li
233 schema:givenName Wenge
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657737640.89
235 rdf:type schema:Person
236 sg:person.0750716622.35 schema:affiliation grid-institutes:grid.415954.8
237 schema:familyName Fang
238 schema:givenName Jing
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750716622.35
240 rdf:type schema:Person
241 sg:pub.10.1007/s00535-010-0331-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008978752
242 https://doi.org/10.1007/s00535-010-0331-4
243 rdf:type schema:CreativeWork
244 sg:pub.10.1007/s10157-011-0464-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022893945
245 https://doi.org/10.1007/s10157-011-0464-7
246 rdf:type schema:CreativeWork
247 sg:pub.10.1007/s11255-013-0480-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048726153
248 https://doi.org/10.1007/s11255-013-0480-5
249 rdf:type schema:CreativeWork
250 sg:pub.10.1007/s11255-016-1487-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009194155
251 https://doi.org/10.1007/s11255-016-1487-5
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/bmt.2010.70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007689036
254 https://doi.org/10.1038/bmt.2010.70
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/sj.bjc.6601699 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051534210
257 https://doi.org/10.1038/sj.bjc.6601699
258 rdf:type schema:CreativeWork
259 sg:pub.10.1186/1471-2334-13-394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007529388
260 https://doi.org/10.1186/1471-2334-13-394
261 rdf:type schema:CreativeWork
262 sg:pub.10.1186/s12882-017-0788-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1099737802
263 https://doi.org/10.1186/s12882-017-0788-y
264 rdf:type schema:CreativeWork
265 grid-institutes:grid.415954.8 schema:alternateName Department of Hepatology, China-Japan Friendship Hospital, Beijing, China
266 Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China
267 schema:name Department of Hepatology, China-Japan Friendship Hospital, Beijing, China
268 Department of Nephrology, China-Japan Friendship Hospital, No.2 East Yinghua Street, Chaoyang District, 100029, Beijing, China
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...